Evidence map›Paper›PMID 33972502›Full record

ArticleTranslational psychiatry2021

Correction: Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.

Simon Loiodice, Wilhelmus H Drinkenburg, Abdallah Ahnaou, Andrew McCarthy, Geoffrey Viardot, Emilie Cayre, Bertrand Rion, Valérie Bertaina-Anglade, Marsel Mano, Philippe L'Hostis and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Simon LoiodiceBiotrial Pharmacology, 7-9 rue Jean-Louis Bertrand, 35042, Rennes, France. simon.loiodice@gmail.com.ORCID http://orcid.org/0000-0001-5013-9666
Wilhelmus H DrinkenburgDepartment of Neuroscience Discovery, Janssen Research & Development, a Division of Janssen Pharmaceutical NV, Turnhoutseweg 30, B-2340, Beerse, Belgium.
Abdallah AhnaouDepartment of Neuroscience Discovery, Janssen Research & Development, a Division of Janssen Pharmaceutical NV, Turnhoutseweg 30, B-2340, Beerse, Belgium.ORCID http://orcid.org/0000-0001-9274-8005
Andrew McCarthyLilly Research Laboratories, Windlesham, Surrey, GU20 6PH, UK.
Geoffrey ViardotBiotrial Neuroscience, Avenue de Bruxelles, 68350, Didenheim, France.
Emilie CayreBiotrial Pharmacology, 7-9 rue Jean-Louis Bertrand, 35042, Rennes, France.
Bertrand RionBiotrial Pharmacology, 7-9 rue Jean-Louis Bertrand, 35042, Rennes, France.
Valérie Bertaina-AngladeBiotrial Neuroscience, Avenue de Bruxelles, 68350, Didenheim, France.
Marsel ManoBiotrial Neuroscience, Avenue de Bruxelles, 68350, Didenheim, France.
Philippe L'HostisBiotrial Neuroscience, Avenue de Bruxelles, 68350, Didenheim, France.
Christophe Drieu La RochelleBiotrial Pharmacology, 7-9 rue Jean-Louis Bertrand, 35042, Rennes, France.
Martien J KasGroningen Institute for Evolutionary Life Sciences, University of Groningen, P.O. Box 11103, 9700 CC, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-4471-8618
Philippe DanjouBiotrial Neuroscience, Avenue de Bruxelles, 68350, Didenheim, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33972502
PMCPMC8110967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.